O ne of the least-understood aspects of ageing is its coordinated and stereotyped progression in all organ systems. Although researchers have long suspected that the brain orchestrates systemic ageing, compelling evidence of this in mammals has been lacking. Furthermore, we have had no clear understanding of how ageing is affected by inflammation, which is a hallmark of age-related diseases such as diabetes, cardiovascular disease, arthritis and Alzheimer's disease. In this issue, Zhang et al. 1 (page 211) help to make this connection by documenting the integration of inflammatory responses with systemic control of ageing by the hypothalamus -a part of the brain that controls growth, reproduction and metabolism*.
Studies in invertebrate models of ageing, such as the nematode worm Caenorhabditis elegans 2, 3 and the fruitfly Drosophila 4 , have suggested that nutrient-sensing and environmental-stress-sensing neurons can regulate ageing of the entire organism. Zhang and colleagues now propose that the hypothalamus, which has similar sensing functions in the mammalian brain, could also exert broad control over the physiological changes we call ageing. Their findings show that activity of the signalling molecule NF-κB increases in many regions of the brain in ageing mice, but that this increase is greatest in the hypothalamus. NF-κB is an important regulator of gene transcription that mediates immune-cell communication and inflammatory responses, and has been implicated previously in the control of gene expression during ageing 5 . Zhang and colleagues' work indicates that activation of NF-κB in microglia (cells in the brain that functionally resemble the macrophages of the immune system) stimulates secretion of the inflammatory cell-signalling molecule TNF-α, which, in turn, stimulates NF-κB signalling in hypothalamic neurons (Fig. 1) .
The authors go on to show that this feedforward loop leads to epigenetic changes (chemical and structural modifications that alter gene expression without changing the DNA sequence) in the gene that encodes gonadotropin-releasing hormone (GnRH), leading to its reduced expression. Moreover, their studies in mice suggest that reduced hypothalamic release of GnRH could contribute to several systemic attributes of ageing, including declining muscle strength, skin atrophy, bone loss, reduced neurogenesis and memory impairment. If validated, the results could have important implications for our understanding and treatment of agerelated diseases, particularly those linked to inflammation.
'Inflammageing' describes the close relationship between low-grade chronic inflammation and ageing that has been linked to a wide spectrum of age-related disorders in various organs, including the brain 6 . Healthy ageing and longevity could relate, in part, to reduced levels of inflammation or strong protective mechanisms that guard against adverse effects of chronic inflammation. Conversely, genetic and environmental factors that promote inflammation or disrupt the mechanisms involved in reducing inflammation seem to confer increased susceptibility to 'accelerated ageing' and age-related disorders such as insulin resistance, metabolic disorders phosphatidylserine without undergoing apoptosis; and dying myoblasts (and other cell types) enhance the fusion of healthy myoblasts without participating in fusion themselves. Indeed, as noted earlier, apoptotic mouse thymocytes, a cell type that does not fuse, could restore fusion in caspase-inhibited myoblasts. It is not clear how phosphatidylserine is presented by apoptotic cells and non-apoptotic cells so as to allow fusion of the latter but not of the former. Additional phosphatidylserinebinding proteins are required for myoblast fusion in vitro 11 , suggesting that phosphatidylserine may affect parallel, yet different, pathways during myoblast fusion.
If the apoptotic cells are not fusing with myotubes, how is the phosphatidylserine-BAI1 signal integrated with the other elements of the fusion machinery? It is likely that, in this case, BAI1 is not participating in the regulation of actin necessary for cell fusion, despite the fact that its influence on fusion depends on ELMO/Dock180/Rac1 signalling within the myotube. Because signalling by BAI1 can restore fusion capacity in caspase-inhibited myoblasts, which have decreased expression of several regulators of muscle-gene transcription 10 , this receptor may target genes essential for myoblast differentiation.
Transient externalization of phosphatidylserine has been observed in other cell-fusing systems -for instance, in trophoblast cells during placental development 12 . So the exposure of this phospholipid may be part of a conserved fusion mechanism. But is phosphatidylserine-BAI1 signalling common to all fusing systems? Moreover, apoptotic epithelial cells have previously been linked to compensatory proliferation and regeneration in a variety of organisms -from Hydra and planarians to Drosophila and mice 13 . It would be interesting to know whether phosphatidylserine-BAI1 signalling also induces proliferation and differentiation of satellite cells, the resident stem cells of skeletal muscle.
The and cardiovascular disease 7 . Accelerated ageing typically involves multiple organ systems, although the effects in some organs might not be seen as clinical symptoms.
At the molecular level, attention has focused on how interplay between several cellular processes -including mitochondrial function, autophagy, the generation of reactive oxygen species and activation of the NLRP3 inflammasome -drives age-dependent inflammatory conditions [8] [9] [10] . Zhang and colleagues' suggestion that inflammageing is driven by the integration of immune and hormonal responses in the hypothalamus is a new para digm for this process. It is possible that the observed hypothalamic NF-κB signalling and decline in GnRH production are a response to local inflammatory molecules produced by microglia, as the authors suggest. Alternatively, this response may be due to systemic signals -dendrites of GnRHproducing hypothalamic neurons extend through the blood-brain barrier, so they are able to sense inflammatory and metabolic signals in the blood 11 . In addition to the classical activity of GnRH in regulating the release of sex steroids involved in development and reproduction (oestrogens and progesterone in females and androgens in males), the hormone might also mediate other functions 12 . Notably, Zhang et al. found that when mice were admini stered GnRH, it abrogated ageing effects and increased the production of new neurons in the hypothalamus and hippocampus (a part of the brain that regulates memory). By contrast, sex steroids did not have these anti-ageing effects. A decrease in gonadal sex steroids is a well-established marker of ageing, but many other hormonal changes occur as well; and some of these ageregulated hormones (such as dehydroepiandrosterone) also regulate inflammation and other immune responses. Thus, interplay between the hormonal and immune systems occurs at multiple levels.
Zhang and colleagues' model may also be relevant to the suggestion -from several studies -that early-life adversity, such as childhood neglect or nutritional deprivation, can increase the risk of age-related disorders later in life 13 . It is possible that, in addition to responding to inflammation, NF-κB signalling functions as an integrator of environmental and experience-related stresses to reset the interactions between the hypothalamus and the hormone-producing pituitary gland, and thus systemically alter hormonal responses. This could be mediated by epigenetic reprogramming of important stress-response genes in the brain that persist throughout adult life. One such gene, NR3C1, encodes the receptor for hormones called glucocorticoids. This receptor mediates stress responses through a feedback loop whereby its activation in the hippocampus inhibits neuronal activity in the hypothalamus. Early-life deprivation in rats or a history of early-life abuse in humans are both associated with epigenetic silencing of NR3C1 (ref. 14) , resulting in heightened sensitivity of the hypothalamus and elevated release of stress hormones.
Another mechanism might involve direct effects of glucocorticoids on the NF-κB pathway. Although glucocorticoids are typically anti-inflammatory, it has been suggested 15 that they can have the opposite effect in some brain regions and stimulate NF-κB signalling. As such, NF-κB signalling may integrate diverse inputs related to stress and inflammation to regulate ageing through changes in hypothalamic function, as well as other target organ systems.
How might hypothalamic regulation of ageing have evolved? Chronic inflammation arises from many kinds of insult, from acute infection to genomic instability. The concept that the hypothalamus can sense inflammation through immune pathways is a new one; just as the hypothalamus responds to nutrient status, its response to inflammation may enable the organism to rapidly adapt to physiol ogical perturbations. Turning down the hypothalamic release of modulators such as GnRH to prevent reproduction and reduce growth may be evolutionarily advantageous during acute infection, injury or deprivation. Although this would have been adaptive for our shorter-lived ancestors, it may accelerate ageing in older individuals and have become apparent now that we live longer. This idea also raises the intriguing possibility that hypothalamic regulation could be therapeutically manipulated to have broad effects on the ageing process and age-related pathology. ■ 1 report that inflammation leads to activation of the signalling molecule NF-κB in the hypothalamus of the brain, and suggest that this contributes to the control of systemic ageing. They show that NF-κB activation in hypothalamic cells called microglia results in production of TNF-α, which, in turn, stimulates NF-κB activity in nearby neurons. This signalling results in epigenetic repression of the gene that encodes gonadotropin-releasing hormone (GnRH), leading to reduced GnRH release from the neurons, which is associated with multiple physiological changes related to ageing, including bone loss, skin atrophy, muscle weakness and memory loss. This pathway might also mediate the effects of a variety of environmental and physiological stressors.
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